ReviewBiomedicines2023

METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer.

Jui-Chuang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.